Trial
NCT02986451
Clarithromycin,Lenalidomide and Dexamethasone for Relapsed/Refractory Myeloma
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Sun Yat-sen University
Collaborators
China Food and Drug Administration
Condition
Relapse/Refractory Multiple Myeloma
Intervention
clarithromycin
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-08-14